Changes in cellular metabolism have an impact on cancer growth and in particular mutations in IDH enzyme dramatically affect glioma biology and prognosis, and cells harboring mutant IDH cannot undergo reductive carboxylation26,27. Here, IDH1 is linked to central nervous system cancer.